These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 6142644
21. Effect of beta blockers on blood lipid profile. Lehtonen A. Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784 [Abstract] [Full Text] [Related]
22. Changes in the lipoprotein profile during antihypertensive therapy. Helgeland A, Leren P, Kjeldsen S, Eide I, Foss OP. Acta Pharmacol Toxicol (Copenh); 1984 May; 54 Suppl 1():75-7. PubMed ID: 6711333 [Abstract] [Full Text] [Related]
23. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men. Durrington PN, Brownlee WC, Large DM. Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062 [Abstract] [Full Text] [Related]
24. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients. Talseth T, Westlie L, Daae L, Vatle S. Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752 [Abstract] [Full Text] [Related]
25. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Arch Intern Med; 1999 Mar 22; 159(6):551-8. PubMed ID: 10090111 [Abstract] [Full Text] [Related]
26. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. Ames RP. Drugs; 1986 Oct 22; 32(4):335-57. PubMed ID: 2877846 [Abstract] [Full Text] [Related]
27. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M, Richter WO, Schwandt P, Holzgreve H. Int J Clin Pharmacol Ther; 1997 Jun 22; 35(6):231-4. PubMed ID: 9208337 [Abstract] [Full Text] [Related]
28. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Pool JL, Taylor AA, Nelson EB. Am J Med; 1989 Aug 16; 87(2A):57S-61S. PubMed ID: 2569825 [Abstract] [Full Text] [Related]
29. Comparative effects of propranolol and prazosin upon serum lipids in thiazide- treated hypertensive patients. Johnson BF, Romero L, Johnson J, Marwaha R. Am J Med; 1984 Feb 27; 76(2A):109-12. PubMed ID: 6367445 [Abstract] [Full Text] [Related]
30. Effects of prazosin on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease: hypertension and other risk factors, Milan, 1983. Lowenstein J. Am J Cardiol; 1984 Jan 27; 53(3):21A-23A. PubMed ID: 6141723 [Abstract] [Full Text] [Related]
31. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension. Houston MC, Burger C, Hays JT, Nadeau J, Swift L, Bradley CA, Olafsson L. Am Heart J; 1990 Jul 27; 120(1):172-9. PubMed ID: 2193493 [Abstract] [Full Text] [Related]
32. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study. Rizos E, Bairaktari E, Kostoula A, Hasiotis G, Achimastos A, Ganotakis E, Elisaf M, Mikhailidis DP. J Cardiovasc Pharmacol Ther; 2003 Jun 27; 8(2):127-34. PubMed ID: 12808486 [Abstract] [Full Text] [Related]
33. Serum lipoproteins during treatment with antihypertensive drugs. Weidmann P, de Courten M, Ferrari P, Böhlen L. J Cardiovasc Pharmacol; 1993 Jun 27; 22 Suppl 6():S98-105. PubMed ID: 7508069 [Abstract] [Full Text] [Related]
34. Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients. Rouffy J, Jaillard J. Am J Med; 1984 Feb 27; 76(2A):105-8. PubMed ID: 6702861 [Abstract] [Full Text] [Related]
35. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension. Samuel P, Chin B, Fenderson RW, Schoenfeld BH, Gonasun LM, Lieberman S. Am J Cardiol; 1986 Feb 12; 57(5):24C-28C. PubMed ID: 3946247 [Abstract] [Full Text] [Related]
36. Adrenergic mechanisms in control of plasma lipid concentrations. Day JL, Metcalfe J, Simpson CN. Br Med J (Clin Res Ed); 1982 Apr 17; 284(6323):1145-8. PubMed ID: 6122483 [Abstract] [Full Text] [Related]
37. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol. Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA. Clin Pharmacol Ther; 1989 Jun 17; 45(6):617-26. PubMed ID: 2567218 [Abstract] [Full Text] [Related]
38. Studies on the effect of prazosin on blood pressure and serum lipids in Japanese hypertensive patients. Saruta T. Am J Med; 1984 Feb 27; 76(2A):117-21. PubMed ID: 6367447 [Abstract] [Full Text] [Related]
39. Metabolic effects of a change in antihypertensive treatment. Lithell H, Aberg H, Selinus I. Am J Med; 1986 Feb 14; 80(2A):114-9. PubMed ID: 3511690 [Abstract] [Full Text] [Related]
40. The effects of beta-adrenergic blocking agents on blood lipid levels. Wolinsky H. Clin Cardiol; 1987 Oct 14; 10(10):561-6. PubMed ID: 2889552 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]